NCT04055311 2026-03-19
Recovery Support for Bladder Cancer Patients and Caregivers
Northwell Health
Phase NA Completed
Clinical Trials
12 trialsNCT06072027 2026-03-19
VISIOCYT2
Institut Paoli-Calmettes
Completed
NCT07481123 2026-03-18
COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT
University of Gaziantep
Phase NA Completed
NCT03258593 2026-03-17
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01616875 2026-03-06
Bristol Bladder Trial
University Hospitals Bristol and Weston NHS Foundation Trust
Phase 2 Completed
NCT01104350 2026-03-05
Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT03348969 2026-03-03
NICSA
Aarhus University Hospital
Phase 4 Completed
NCT06281691 2026-03-03
GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
Aarhus University Hospital
Completed
NCT07445451 2026-03-03
TURBT
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Phase NA Completed
NCT04321707 2026-02-27
MAINTAIN
Aarhus University Hospital
Phase NA Completed
NCT04610671 2026-02-27
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT04172675 2026-02-24
A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Janssen Research & Development, LLC
Phase 2 Completed